Consun Pharmaceutical (01681) Announces Updates on Share Issuance and Repurchase

Bulletin Express

01/19

Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was 849,052,607 shares.

Between 9 January and 16 January 2026, a total of 574,331 shares were issued due to exercises of share options under the Share Option Scheme adopted on 2 December 2013. The exercise prices ranged from HKD 3.7807 to HKD 4.243 per share.

Additionally, 8,385,000 shares repurchased from 14 October 2025 to 17 December 2025 were cancelled on 16 January 2026 at a volume-weighted average repurchase price of HKD 14.939. After these transactions, the closing balance on 16 January 2026 was 841,241,938 shares.

The announcement also noted 100,000 shares (repurchased on 6 October 2025 at HKD 15.505) that were pending cancellation. All procedures were stated to have complied with relevant rules, laws, and listing requirements.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1170238152"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1170238152\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1170238152?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-19 20:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170238152","market":"hk","top_or_hot":-1,"title":"Consun Pharmaceutical (01681) Announces Updates on Share Issuance and Repurchase","media":"Bulletin Express","content":"<p>Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was 849,052,607 shares.</p>\n<p>Between 9 January and 16 January 2026, a total of 574,331 shares were issued due to exercises of share options under the Share Option Scheme adopted on 2 December 2013. The exercise prices ranged from HKD 3.7807 to HKD 4.243 per share.</p>\n<p>Additionally, 8,385,000 shares repurchased from 14 October 2025 to 17 December 2025 were cancelled on 16 January 2026 at a volume-weighted average repurchase price of HKD 14.939. After these transactions, the closing balance on 16 January 2026 was 841,241,938 shares.</p>\n<p>The announcement also noted 100,000 shares (repurchased on 6 October 2025 at HKD 15.505) that were pending cancellation. All procedures were stated to have complied with relevant rules, laws, and listing requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consun Pharmaceutical (01681) Announces Updates on Share Issuance and Repurchase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsun Pharmaceutical (01681) Announces Updates on Share Issuance and Repurchase\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-01-19 20:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was 849,052,607 shares.</p>\n<p>Between 9 January and 16 January 2026, a total of 574,331 shares were issued due to exercises of share options under the Share Option Scheme adopted on 2 December 2013. The exercise prices ranged from HKD 3.7807 to HKD 4.243 per share.</p>\n<p>Additionally, 8,385,000 shares repurchased from 14 October 2025 to 17 December 2025 were cancelled on 16 January 2026 at a volume-weighted average repurchase price of HKD 14.939. After these transactions, the closing balance on 16 January 2026 was 841,241,938 shares.</p>\n<p>The announcement also noted 100,000 shares (repurchased on 6 October 2025 at HKD 15.505) that were pending cancellation. All procedures were stated to have complied with relevant rules, laws, and listing requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣药业","start_time":0,"source_url":"","article_id":"1170238152","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170238152","pubTimestamp":1768826554,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业(01681)公布股份发行及购回更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"Consun Pharmaceutical Group Limited submitted a Next Day Disclosure Return on 19 January 2026, disclosing changes in its issued ordinary shares. The opening balance as of 6 January 2026 was 849,052,607 shares.\nBetween 9 January and 16 January 2026, a total of 574,331 shares were issued due to exercises of share options under the Share Option Scheme adopted on 2 December 2013. The exercise prices ranged from HKD 3.7807 to HKD 4.243 per share.\nAdditionally, 8,385,000 shares repurchased from 14 October 2025 to 17 December 2025 were cancelled on 16 January 2026 at a volume-weighted average repurchase price of HKD 14.939. After these transactions, the closing balance on 16 January 2026 was 841,241,938 shares.\nThe announcement also noted 100,000 shares (repurchased on 6 October 2025 at HKD 15.505) that were pending cancellation. All procedures were stated to have complied with relevant rules, laws, and listing requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}